# Perpetua Resources Corp.: overview PPTA · Nasdaq · CIK 1526243 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/ppta.md) · [Financials](/companies/ppta/financials.md) · [Filings](/companies/ppta/filings.md) · [Insiders](/companies/ppta/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.05)](/filings/0001104659-25-112609.md) | not reported | [(0.12)](/filings/0001104659-26-058253.md) | [(0.08)](/filings/0001104659-26-097134.md) | [(0.24)](/filings/0001104659-25-112609.md) | not reported | [(0.39)](/filings/0001104659-26-058253.md) | [(0.78)](/filings/0001104659-26-097134.md) | | Free cash flow | $m | [(1.3) d](/filings/0001104659-25-112609.md) | [(0.1) d](/filings/0001104659-26-037403.md) | not reported | not reported | [(12.4) d](/filings/0001104659-25-112609.md) | [(60.3) d](/filings/0001104659-26-037403.md) | [(46.4)](/filings/0001104659-26-058253.md) | [(93.9) d](/filings/0001104659-26-097134.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.66](/filings/0001104659-23-033343.md) | [(0.46)](/filings/0001104659-24-039054.md) | [(0.30)](/filings/0001410578-25-000385.md) | [(0.22)](/filings/0001104659-26-037403.md) | [(1.08)](/filings/0001104659-26-037403.md) | | Free cash flow | $m | [(28.7)](/filings/0001104659-23-033343.md) | [(24.9)](/filings/0001104659-24-039054.md) | [(21.3)](/filings/0001410578-25-000385.md) | [(12.1)](/filings/0001104659-26-037403.md) | [(106)](/filings/0001104659-26-037403.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ppta/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [PAULSON & CO. INC.](/funds/1035674.md) | 2026-06-30 | $671.5m | 32,347,299 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $110.2m | 5,307,387 | | Added +18,215 | | [Tidal Investments LLC](/funds/1600064.md) | 2026-06-30 | $101.6m | 4,894,757 | | Reduced −465,327 | | [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $60.7m | 2,943,893 | | Reduced −22,815 | | [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $57.9m | 2,789,423 | | Added +354,513 | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $54.4m | 2,622,292 | | Reduced −81,326 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $50.8m | 2,447,665 | | Reduced −34,289 | | [SPROTT INC.](/funds/1512920.md) | 2026-06-30 | $43.0m | 2,072,699 | | Reduced −188,903 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $35.1m | 1,692,925 | | Added +151,764 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $34.0m | 1,638,700 | Call | Added +208,000 | ## Recent filings [All 468 filings](/companies/ppta/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 17:30 ET | [8-K](/filings/0001104659-26-118875.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001104659-26-118875 | | 2026-09-28 | 06:49 ET | [8-K](/filings/0001104659-26-111136.md) | 7.01 Regulation FD disclosure | 0001104659-26-111136 | | 2026-08-17 | 06:39 ET | [8-K](/filings/0001104659-26-097512.md) | 7.01 Regulation FD disclosure | 0001104659-26-097512 | | 2026-08-14 | 16:10 ET | [10-Q](/filings/0001104659-26-097134.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097134 | | 2026-06-10 | 16:49 ET | [8-K](/filings/0001104659-26-072399.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-072399 | | 2026-06-01 | 07:40 ET | [8-K](/filings/0001104659-26-068574.md) | 8.01 Other events | 0001104659-26-068574 | | 2026-05-21 | 16:09 ET | [8-K](/filings/0001104659-26-065145.md) | 8.01 Other events | 0001104659-26-065145 | | 2026-05-11 | 07:00 ET | [10-Q](/filings/0001104659-26-058253.md) | Quarterly report, period 2026-03-31 | 0001104659-26-058253 | | 2026-04-24 | 07:02 ET | [DEF 14A](/filings/0001104659-26-048110.md) | Proxy statement, period 2026-06-04 | 0001104659-26-048110 | | 2026-04-22 | 16:30 ET | [8-K](/filings/0001104659-26-046859.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-046859 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-037403.md), filed Mar 31, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1526243 - Tickers: PPTA - Exchange: Nasdaq - SIC code: 1040 Gold and Silver Ores - State of incorporation: A1 - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:31 ET. No prices; not investment advice.